4//SEC Filing
Stellar Biotechnologies, Inc. 4
Accession 0001102624-14-001896
$EDSACIK 0001540159operating
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 7:57 PM ET
Size
5.8 KB
Accession
0001102624-14-001896
Insider Transaction Report
Form 4
BAXTER GREGORY T.
Director
Transactions
- Award
Stock Option (Right To Buy)
2014-11-12+12,500→ 12,500 totalExercise: $1.34Exp: 2021-11-12→ Common Shares (12,500 underlying)
Footnotes (2)
- [F1]The options are exercisable at a price of C$1.52. The U.S. dollar price reported on this Form 4 in column 2 reflects the U.S. dollar equivalent exercise price on the date of grant, calculated at the closing price for cable transfers in Canadian dollars as reported by Bloomberg on such date of U.S.$1.00 = CDN$1.1311.
- [F2]The option was issued as consideration for services as a member of the Issuer's Scientific Advisory Board. One-third of the option vested immediately, one-third of the option vests on the first anniversary of November 12, 2014, and one-third of the option vests 18 months after November 12, 2014.
Documents
Issuer
Stellar Biotechnologies, Inc.
CIK 0001540159
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001540159
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 7:57 PM ET
- Size
- 5.8 KB